National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Radiation Countermeasures
 Program
 Research Areas
 Resources
 Funding
 Summaries and Publications
 Congressional Testimonies


Medical Countermeasures Against Radiological and Nuclear Threats

Centers for Medical Countermeasures Against Radiation (CMCR) Public Briefing

December 15, 2004

RFA AI-04-045 Centers for Medical Countermeasures Against Radiation 

Description

The National Institute of Allergy and Infectious Diseases would like to announce that an informational session for individuals representing groups considering submission of applications in response to NIAID’s RFA No. AI-04-045 (http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-04-045.html), titled “Centers for Medical Countermeasures Against Radiation,” will be held from 1 p.m. to 5 p.m. (Eastern Standard Time) on December 15, 2004. 

The meeting will be held in Room 2C-13, 10401 Fernwood Drive, Bethesda, MD 20892. Staff from the NIH Centers for Medical Countermeasures Against Radiation Program and the Division of Extramural Activities will provide information about the Program and application procedures, and will be available to answer questions pertinent to preparing applications in response to this RFA. Advance registration is not required.

This meeting will also be available through a live broadcast allowing for questions from off-site locations. Please check http://videocast.nih.gov/FutureEvents.asp for videocast information regarding this event. A videotape of this meeting will be made available for future viewing at http://videocast.nih.gov/PastEvents.asp.

Draft Agenda 

1:00 – 1:15 Welcome and introduction to public briefing (Allan Czarra, NIAID)

1:15 – 1:30 Overview: HHS/Bioshield and NIH/NIAID collaboration (John Carney, HHS)

1:30 – 1:40 Overview: NIH Biodefense Program (Ernest Takafuji, NIAID)

1:40 – 1:50 Overview: NIH Medical Countermeasures Against Radiological and Nuclear Threats Program (Daniel Rotrosen, NIAID)

1:50 – 2:15 CMCR program overview/program issues (Helen Quill, NIAID)

2:15 – 2:30 BREAK

2:30 – 3:00 CMCR review criteria/review issues (Kirt Vener, NCI)

3:00 – 3:20 CMCR grants management/budget issues (Ann Devine, NIAID)

3:20 – 3:40 Regulatory issues (Christine Czarniecki)

3:40 – 5:00 Questions/discussion

Slides

Implementing Project Bioshield: Acquisition of Medical Countermeasures for Biodefense—John Carney, HHS (PDF)

Centers for Medical Countermeasures Against Radiation: DAIT Regulatory Affairs—Christine Czarniecki, DAIT

Centers for Medical Countermeasures Against Radiation: RFA AI-04-045: U19 Mechanism—Timothy Meeker, Lalita Palekar, NCI

Centers for Medical Countermeasures Against Radiation—Helen Quill, DAIT

Budget Considerations: Centers for Medical Countermeasures Against Radiation—Gregory Smith, NIAID Grants Management

NIH Plans for Development of Radiological and Nuclear Medical Countermeasures—Ernest Takafuji, NIAID

back to top

Highlights

RFA-09-036: Centers for Medical Countermeasures Against Radiation (U19)

RFP-NIAID-DAIT-NIHAI2009079: Radiation/Nuclear Medical Countermeasure Product Development Support Services

BAA-NIAID-DAIT-NIHAI2009051: Development of Oral Radionuclide Decorporation Agents for Use in Radionuclide Decorporation in Radiological Emergencies

BAA-NIAID-DAIT-NIHAI2009060: Development of Oral Form of Diethylenetriaminepentaacetate (DTPA) for Use in Radionuclide Decorporation – Radiological Emergency 

PA-09-093: Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR[R43/R44]).  Standard SBIR receipt dates.

Solicitation: BAA-BARDA-09-34: BARDA Broad Agency Announcement for the Advanced Research and Development of Chemical, Biological, Radiological, and Nuclear Medical Countermeasures

See Also

  • Radiological and Nuclear Threats News Releases
  • Division of Allergy, Immunology, and Transplantation (DAIT)
  • Biodefense—The NIAID Biodefense Web site includes biodefense-related information for biomedical researchers, the public, and the media.

  • Highlights

    RFA-09-036: Centers for Medical Countermeasures Against Radiation (U19)

    RFP-NIAID-DAIT-NIHAI2009079: Radiation/Nuclear Medical Countermeasure Product Development Support Services

    BAA-NIAID-DAIT-NIHAI2009051: Development of Oral Radionuclide Decorporation Agents for Use in Radionuclide Decorporation in Radiological Emergencies

    BAA-NIAID-DAIT-NIHAI2009060: Development of Oral Form of Diethylenetriaminepentaacetate (DTPA) for Use in Radionuclide Decorporation – Radiological Emergency 

    PA-09-093: Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR[R43/R44]).  Standard SBIR receipt dates.

    Solicitation: BAA-BARDA-09-34: BARDA Broad Agency Announcement for the Advanced Research and Development of Chemical, Biological, Radiological, and Nuclear Medical Countermeasures

    See Also

  • Radiological and Nuclear Threats News Releases
  • Division of Allergy, Immunology, and Transplantation (DAIT)
  • Biodefense—The NIAID Biodefense Web site includes biodefense-related information for biomedical researchers, the public, and the media.